602
Views
38
CrossRef citations to date
0
Altmetric
Review Article

The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment

, , , &
Pages 195-201 | Received 30 Jun 2011, Accepted 10 Jul 2011, Published online: 24 Aug 2011
 

Abstract

Inflammation and cancer are two independent biological events that can play an interdependent role. The model of such interaction is represented by Hodgkin lymphoma (HL), where the microenvironment is dominated by an extensive mixed, potentially cellular inflammatory infiltrate that plays a decisive role in the pathobiology of HL. In this review we summarize updated information on the complex interactions between Hodgkin Reed–Sternberg (HRS) cells and their tissue microenvironment, highlighting the functional role of CD40/CD40L and interferon regulatory factor 4 (IRF4).

Acknowledgements

This work was supported in part by the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.), Milan, Italy; the Ministero della Salute, Ricerca Finalizzata FSN, I.R.C.C.S., Rome, Italy; and by grants from the Ministero della Salute, Rome, within the framework of the “Progetto Integrato Oncologia-Advanced Molecular Diagnostics” project (RFPS-2006-2-339694.1; RFPS-2006-2-339723.2).

Potential conflict of interest:

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.